Oncodesign Services and Nexus BioQuest have formed a preclinical research [...]

Resolution Therapeutics has treated the final patient in its Phase [...]

A study published in The New England Journal of Medicine [...]

Tozorakimab has met its primary endpoint in two replicate Phase [...]

Researchers identify an IL-1β-driven inflammatory loop behind bone damage and [...]

CytoAgents will present new clinical safety data for CTO1681 at [...]

Appointment strengthens expertise in targeted protein degradation as company advances [...]

Company says appointments of Barbara Duncan and Stephen Dilly will [...]

Glen Clova Scientific has moved its R&D operations to the [...]